79 related articles for article (PubMed ID: 19400303)
1. Anti-HIV dendrimeric peptides.
Yu Q; Li L; Tam JP
Adv Exp Med Biol; 2009; 611():539-40. PubMed ID: 19400303
[No Abstract] [Full Text] [Related]
2. Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues.
Oishi S; Kamitani H; Kodera Y; Watanabe K; Kobayashi K; Narumi T; Tomita K; Ohno H; Naito T; Kodama E; Matsuoka M; Fujii N
Org Biomol Chem; 2009 Jul; 7(14):2872-7. PubMed ID: 19582296
[TBL] [Abstract][Full Text] [Related]
3. Bioorganic synthesis of end-capped anti-HIV peptides by simultaneous cyanocysteine-mediated cleavages of recombinant proteins.
Tanaka M; Kajiwara K; Tokiwa R; Watanabe K; Ohno H; Tsutsumi H; Hata Y; Izumi K; Kodama E; Matsuoka M; Oishi S; Fujii N
Bioorg Med Chem; 2009 Nov; 17(21):7487-92. PubMed ID: 19811922
[TBL] [Abstract][Full Text] [Related]
4. Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
Jiang S; Debnath AK
Biochem Biophys Res Commun; 2000 Mar; 269(3):641-6. PubMed ID: 10720469
[TBL] [Abstract][Full Text] [Related]
5. Biological activities and potential health benefits of bioactive peptides derived from marine organisms.
Ngo DH; Vo TS; Ngo DN; Wijesekara I; Kim SK
Int J Biol Macromol; 2012 Nov; 51(4):378-83. PubMed ID: 22683669
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.
Lee MK; Kim HK; Lee TY; Hahm KS; Kim KL
Exp Mol Med; 2006 Feb; 38(1):18-26. PubMed ID: 16520549
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.
Secchi M; Longhi R; Vassena L; Sironi F; Grzesiek S; Lusso P; Vangelista L
Chem Biol; 2012 Dec; 19(12):1579-88. PubMed ID: 23261601
[TBL] [Abstract][Full Text] [Related]
8. Picture story. Keeping HIV out.
Konforti B
Nat Struct Biol; 1999 Nov; 6(11):1004. PubMed ID: 10542088
[No Abstract] [Full Text] [Related]
9. [Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity].
Riakhovskiĭ VV; Malekin SI; Nosova VM; Kisin AV; Krugliak IuL; Kurochkin VK
Bioorg Khim; 1999 Jul; 25(7):499-504. PubMed ID: 10563202
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of peptidic fusion inhibitors derived from HIV-1 gp41 with partial D-amino acid substitutions.
Gaston F; Granados GC; Madurga S; Rabanal F; Lakhdar-Ghazal F; Giralt E; Bahraoui E
ChemMedChem; 2009 Apr; 4(4):570-81. PubMed ID: 19206122
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
[TBL] [Abstract][Full Text] [Related]
12. Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells.
Löhr M; Kibler KV; Zachary I; Jeang KT; Selwood DL
Biochem Biophys Res Commun; 2003 Jan; 300(2):609-13. PubMed ID: 12504126
[TBL] [Abstract][Full Text] [Related]
13. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
Eckert DM; Kim PS
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11187-92. PubMed ID: 11572974
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
[TBL] [Abstract][Full Text] [Related]
15. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
16. Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules.
Sluis-Cremer N; Tachedjian G
Eur J Biochem; 2002 Nov; 269(21):5103-11. PubMed ID: 12392542
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
[TBL] [Abstract][Full Text] [Related]
18. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
20. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
Shu W; Liu J; Ji H; Radigen L; Jiang S; Lu M
Biochemistry; 2000 Feb; 39(7):1634-42. PubMed ID: 10677212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
